š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clin...
Status
Completed
Location
Jiangsu Province Center for Disease Control and Prevention
Start Date
2020-04-20
Trial ID
NCT04334577
Treatments Being Tested
The purpose of this study is to assess immunogenicity and safety of GSK Bio...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-04-12
Trial ID
NCT03439657
Treatments Being Tested
This study will compare the safety and immunogenicity of ZOSTAVAXā¢ (V211) a...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01385566
A study in two parts (Part A and Part B) to evaluate the responsiveness of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00886613
Treatments Being Tested
Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clin...
Status
Completed
Location
Hunan Provincial Center for Disease Control and Prevention
Start Date
2017-10-06
Trial ID
NCT03314103
Treatments Being Tested
The purpose of this study is to assess immunogenicity, reactogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-07
Trial ID
NCT02052596
Treatments Being Tested
This is Phase 4 clinical trial of live attenuated varicella vaccines manufa...
Status
Unknown
Location
Laian Center for Disease Control and Prevention
Start Date
2022-07-30
Trial ID
NCT05460429
Treatments Being Tested
The purpose of this study is to assess immunogenicity, reactogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-03
Trial ID
NCT01954251
Primary objective: To demonstrate whether or not ZOSTAVAXĀ® at minimum rele...
Status
Completed
Location
Multiple Locations
Start Date
2008-05-14
Trial ID
NCT00681031
Treatments Being Tested
This study will determine if ZOSTAVAXā¢ is safe, tolerable, and immunogenic ...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-31
Trial ID
NCT01527370
Treatments Being Tested